Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Barrow

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Molecules (Basel, Switzerland)|April 24, 2015
Evaluation of New Dihydrophthalazine-Appended 2,4-Diaminopyrimidines against Bacillus anthracis: Improved Syntheses Using a New Pincer ComplexNagendra Prasad Muddala, Baskar Nammalwar, Subhashini Selvaraju, et al.
Bioorganic & Medicinal Chemistry|December 2, 2014
Modified 2,4-diaminopyrimidine-based dihydrofolate reductase inhibitors as potential drug scaffolds against Bacillus anthracisBaskar Nammalwar, Christina R Bourne, Nancy Wakeham, et al.
Molecules (Basel, Switzerland)|March 20, 2014
Synthesis and biological evaluation of 2,4-diaminopyrimidine-based antifolate drugs against Bacillus anthracisBaskar Nammalwar, N Prasad Muddala, Christina R Bourne, et al.
Neurosurgical Focus|December 2, 2019
Comprehensive review of imaging of intracranial aneurysms and angiographically negative subarachnoid hemorrhageBrian M Howard, Ranliang Hu, Jack W Barrow, et al.
Biochimica Et Biophysica Acta|March 18, 2008
Examination of intrinsic sulfonamide resistance in Bacillus anthracis: a novel assay for dihydropteroate synthaseMichelle Wright Valderas, Babak Andi, William W Barrow, et al.
Chemmedchem|August 30, 2012
Inhibition of bacterial dihydrofolate reductase by 6-alkyl-2,4-diaminopyrimidinesBaskar Nammalwar, Christina R Bourne, Richard A Bunce, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
Potential drug targets for Mycobacterium avium defined by radiometric drug-inhibitor combination techniquesN Rastogi, K S Goh, E L Wright, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium aviumW W Barrow, E L Wright, K S Goh, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductaseW J Suling, L E Seitz, V Pathak, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1996
Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studiesE L Wright, D C Quenelle, W J Suling, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Molecules (Basel, Switzerland)|April 24, 2015
Evaluation of New Dihydrophthalazine-Appended 2,4-Diaminopyrimidines against Bacillus anthracis: Improved Syntheses Using a New Pincer ComplexNagendra Prasad Muddala, Baskar Nammalwar, Subhashini Selvaraju, et al.
Bioorganic & Medicinal Chemistry|December 2, 2014
Modified 2,4-diaminopyrimidine-based dihydrofolate reductase inhibitors as potential drug scaffolds against Bacillus anthracisBaskar Nammalwar, Christina R Bourne, Nancy Wakeham, et al.
Molecules (Basel, Switzerland)|March 20, 2014
Synthesis and biological evaluation of 2,4-diaminopyrimidine-based antifolate drugs against Bacillus anthracisBaskar Nammalwar, N Prasad Muddala, Christina R Bourne, et al.
Neurosurgical Focus|December 2, 2019
Comprehensive review of imaging of intracranial aneurysms and angiographically negative subarachnoid hemorrhageBrian M Howard, Ranliang Hu, Jack W Barrow, et al.
Biochimica Et Biophysica Acta|March 18, 2008
Examination of intrinsic sulfonamide resistance in Bacillus anthracis: a novel assay for dihydropteroate synthaseMichelle Wright Valderas, Babak Andi, William W Barrow, et al.
Chemmedchem|August 30, 2012
Inhibition of bacterial dihydrofolate reductase by 6-alkyl-2,4-diaminopyrimidinesBaskar Nammalwar, Christina R Bourne, Richard A Bunce, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
Potential drug targets for Mycobacterium avium defined by radiometric drug-inhibitor combination techniquesN Rastogi, K S Goh, E L Wright, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium aviumW W Barrow, E L Wright, K S Goh, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductaseW J Suling, L E Seitz, V Pathak, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1996
Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studiesE L Wright, D C Quenelle, W J Suling, et al.
Pageof 9